Page last updated: 2024-10-17

bupropion and Hemolytic-Uremic Syndrome

bupropion has been researched along with Hemolytic-Uremic Syndrome in 1 studies

Bupropion: A propiophenone-derived antidepressant and antismoking agent that inhibits the uptake of DOPAMINE.
bupropion : An aromatic ketone that is propiophenone carrying a tert-butylamino group at position 2 and a chloro substituent at position 3 on the phenyl ring.

Hemolytic-Uremic Syndrome: A syndrome that is associated with microvascular diseases of the KIDNEY, such as RENAL CORTICAL NECROSIS. It is characterized by hemolytic anemia (ANEMIA, HEMOLYTIC); THROMBOCYTOPENIA; and ACUTE RENAL FAILURE.

Research Excerpts

ExcerptRelevanceReference
"Bupropion hydrochloride is an effective drug for people who want stop smoking, and its use has recently increased in many countries."1.32Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome after bupropion treatment for smoking cessation. ( Fianchi, L; Leone, G; Mele, L; Pagano, L; Voso, MT, 2003)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mele, L1
Voso, MT1
Fianchi, L1
Leone, G1
Pagano, L1

Other Studies

1 other study available for bupropion and Hemolytic-Uremic Syndrome

ArticleYear
Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome after bupropion treatment for smoking cessation.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2003, Volume: 14, Issue:1

    Topics: Bupropion; Female; Hemolytic-Uremic Syndrome; Humans; Middle Aged; Plasma Exchange; Purpura, Thrombo

2003